Data / Form D filings / Crosslink Therapeutics Inc.
Crosslink Therapeutics Inc.: Form D filing
Crosslink Therapeutics Inc., a pharmaceuticals company in Boston, MA, filed a Form D with the SEC in 2026. The latest, on October 20, 2026, reports $5.5 million sold of a $5.5 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 349-351 NEWBURY STREET, Boston, MA, 02115
- Phone
- (404) 861-1253
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2067583
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20 | New notice | $5,500,000 | $5,500,000 | 8 | Oct 8 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald D. Seidel, III | Executive Officer, Director | |
| Andrew King | Director | |
| Lou Tartaglia | Director | |
| Rodolfo Chaparro | Director | |
| David Fallace | Director | |
| Cameron Gallagher | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21
Every Form D from the week of Oct 19 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Crosslink Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.